OptiNose, Inc. Common Stock

$17.31 -$0.28 -1.62%

Shares Bought2
Shares Sold2
Shares Owned0
Last Price$17.31
Total Return-$0.20
Range Today$16.89 - $18.17
52 Week Range$15.01 - $21.50
Market Cap$653.65M
P/E Ratio-

OptiNose, Inc. is a commercial stage specialty pharmaceutical company, focused on the development and commercialization of products for patients treated by ear, nose, throat and allergy specialists. Its products include the following therapies: AVP-825, for migraine, OPN-375, for chronic sinusitis with nasal polyps; OPN-375, for chronic sinusitis or recurrent sinusitis; and OPN-300, for autism. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in May 2010 and is headquartered in Yardley, PA.

Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-10-26 17:03 17-10-31 15:51 $20.08 $19.98 -$0.10 -0.49% crizisaround kurt_woloch
17-10-27 13:30 17-10-30 13:32 $20.10 $20.00 -$0.10 -0.50% crizisaround